MedTrace Logo

E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research

NCT03132506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2025-01-22

No results posted yet for this study

Summary

Evaluation of patient acceptance and characterization of response behaviour for web-based compared with respective paperbacked patient reported outcomes.

Conditions

  • Breast Cancer Metastatic

Interventions

OTHER

patient-reported-outcomes

Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes

Sponsors & Collaborators

  • National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany

    collaborator UNKNOWN

  • Department of Gynecology and Obstetrics, University Hospital Heidelberg, Germany

    collaborator UNKNOWN

  • Department of Gynecology and Obstetrics, University Hospital Erlangen, Germany

    collaborator UNKNOWN

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2024-07-17
Completion
2024-07-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03132506 on ClinicalTrials.gov